These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
691 related items for PubMed ID: 15474718
1. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J. Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718 [Abstract] [Full Text] [Related]
2. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. Orr B, Douce G, Baillie S, Parton R, Coote J. Vaccine; 2007 Jan 02; 25(1):64-71. PubMed ID: 16916566 [Abstract] [Full Text] [Related]
3. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG. Infect Immun; 2006 Dec 02; 74(12):6797-805. PubMed ID: 16982827 [Abstract] [Full Text] [Related]
4. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. Hormozi K, Parton R, Coote J. FEMS Immunol Med Microbiol; 1999 Apr 02; 23(4):273-82. PubMed ID: 10225286 [Abstract] [Full Text] [Related]
8. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A. Dev Biol Stand; 1997 Apr 02; 89():315-20. PubMed ID: 9272365 [Abstract] [Full Text] [Related]
9. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model. Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH. BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777 [Abstract] [Full Text] [Related]
13. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo. Xing DK, Canthaboo C, Corbel MJ. Vaccine; 2000 Apr 14; 18(20):2110-9. PubMed ID: 10715525 [Abstract] [Full Text] [Related]
16. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Canthaboo C, Williams L, Xing DK, Corbel MJ. Vaccine; 2000 Nov 08; 19(6):637-43. PubMed ID: 11090715 [Abstract] [Full Text] [Related]
19. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF. Clin Exp Immunol; 2006 Jun 08; 144(3):543-51. PubMed ID: 16734625 [Abstract] [Full Text] [Related]
20. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Hodder SL, Cherry JD, Mortimer EA, Ford AB, Gornbein J, Papp K. Clin Infect Dis; 2000 Jul 08; 31(1):7-14. PubMed ID: 10913389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]